Radical Gastrectomy Combined with Modified Gastric Bypass Surgery for Gastric Cancer Patients with Type 2 Diabetes
- PMID: 25677989
- DOI: 10.1007/s12013-015-0546-3
Radical Gastrectomy Combined with Modified Gastric Bypass Surgery for Gastric Cancer Patients with Type 2 Diabetes
Abstract
The aim of the study is to explore the effectiveness of radical gastrectomy with modified gastric bypass surgery in treating gastric cancer patients with type 2 diabetes mellitus (T2DM). A total of 93 patients with gastric cancer and T2DM were treated in our hospital and enrolled in this study. Patients in group A (n = 30) had a body mass index (BMI) of >28 kg/m(2). Radical total gastrectomy and modified esophagojejunal Roux-en-y anastomosis were performed on 13 patients, and radical distal subtotal gastrectomy and gastric remnant jejunal Roux-en-y anastomosis were performed on 17 patients. The data from groups B, C, and D were derived from 63 patients with gastric cancer and diabetes who were admitted to our hospital from January 2005 to July 2012. All patients underwent radical gastrectomy (including 21 cases of gastric cancer surgery with Billroth I anastomosis, 25 cases of radical gastrectomy with Roux-en-Y anastomosis and BMI >28 kg/m(2), and 17 cases with BMI <28 kg/m(2)). The BMI, fasting blood glucose (FBG), meal after the 2-hour glucose (2 h PBG), C-peptide (C-P), and glycosylated hemoglobin (HbAIC) data were collected before and 6 and 12 months after surgery. In groups A and D, BMI, FBG, 2 h PBG, C-P, and HbAIC at the 6th and 12th post-operative months were significantly lower than those before the surgery. In group B, BMI, FBG, 2 h PBG, C-P, and HbAIC at the 6th and 12th post-operative months did not decrease significantly, when compared with the pre-operative levels. In group C, BMI, FBG, 2 h PBG, C-P, and HbAIC at the 6th and 12th post-operative months decreased but showed no statistical significance. However, in comparison, groups A C showed significant differences after the surgeries. Radical gastrectomy combined with modified gastric bypass surgery is effective in treating patients with gastric cancer with type 2 diabetes, although this requires further investigation.
Keywords: Gastric cancer; Radical gastrectomy; Roux-en-y anastomosis; Type 2 diabetes mellitus.
Similar articles
-
The Metabolic Effects and Effectiveness of the Different Reconstruction Methods used in Gastric Cancer Surgery: A Systematic Review and Meta-Analysis.Sci Rep. 2024 Oct 8;14(1):23477. doi: 10.1038/s41598-024-72456-2. Sci Rep. 2024. PMID: 39379429 Free PMC article.
-
Comparison of different gastric bypass procedures in gastric carcinoma patients with type 2 diabetes mellitus.World J Gastroenterol. 2014 Dec 28;20(48):18427-31. doi: 10.3748/wjg.v20.i48.18427. World J Gastroenterol. 2014. PMID: 25561812 Free PMC article.
-
[Effect of ROUX-en-Y anastomosis and Billroth-II anastomosis after subtotal gastrectomy on blood glucose in type 2 diabetic patients].Nan Fang Yi Ke Da Xue Xue Bao. 2010 Jun;30(6):1288-90, 1294. Nan Fang Yi Ke Da Xue Xue Bao. 2010. PMID: 20584659 Chinese.
-
Comparison of the effects of Roux-en-Y gastrojejunostomy and LRYGB with small stomach pouch on type 2 diabetes mellitus in patients with BMI<35 kg/m(2).Surg Obes Relat Dis. 2015 Sep-Oct;11(5):1061-8. doi: 10.1016/j.soard.2014.12.029. Epub 2015 Jan 5. Surg Obes Relat Dis. 2015. PMID: 25843397 Clinical Trial.
-
[172 consecutive total gastrectomies for gastric cancer with Roux-en-Y loop reconstruction and without fistulization of the esophago-jejunal anastomosis].Tumori. 2003 Jul-Aug;89(4 Suppl):29-31. Tumori. 2003. PMID: 12903538 Review. Italian.
Cited by
-
Glycaemic control in people with type 2 diabetes mellitus during and after cancer treatment: A systematic review and meta-analysis.PLoS One. 2017 May 3;12(5):e0176941. doi: 10.1371/journal.pone.0176941. eCollection 2017. PLoS One. 2017. PMID: 28467470 Free PMC article.
-
Nutritional safety of oncometabolic surgery for early gastric cancer patients: a prospective single-arm pilot study using a historical control group for comparison.Surg Endosc. 2020 Jan;34(1):275-283. doi: 10.1007/s00464-019-06763-5. Epub 2019 Mar 29. Surg Endosc. 2020. PMID: 30927123
-
The Metabolic Effects and Effectiveness of the Different Reconstruction Methods used in Gastric Cancer Surgery: A Systematic Review and Meta-Analysis.Sci Rep. 2024 Oct 8;14(1):23477. doi: 10.1038/s41598-024-72456-2. Sci Rep. 2024. PMID: 39379429 Free PMC article.
-
Oncometabolic surgery in gastric cancer patients with type 2 diabetes.Sci Rep. 2022 Jul 13;12(1):11853. doi: 10.1038/s41598-022-15404-2. Sci Rep. 2022. PMID: 35831319 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous